[go: up one dir, main page]

US5098835A - Process for producing l-threonine by fermentation - Google Patents

Process for producing l-threonine by fermentation Download PDF

Info

Publication number
US5098835A
US5098835A US07/357,690 US35769089A US5098835A US 5098835 A US5098835 A US 5098835A US 35769089 A US35769089 A US 35769089A US 5098835 A US5098835 A US 5098835A
Authority
US
United States
Prior art keywords
threonine
sub
leucine
providencia rettgeri
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US07/357,690
Inventor
Katsushige Yamada
Hiromi Tsutsui
Kyousuke Yotsumoto
Makoto Shirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9958985A external-priority patent/JPS61260891A/en
Priority claimed from JP4258086A external-priority patent/JPH0673460B2/en
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Application granted granted Critical
Publication of US5098835A publication Critical patent/US5098835A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/08Lysine; Diaminopimelic acid; Threonine; Valine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/873Proteus

Definitions

  • This invention relates to a process for producing L-threonine by fermentation.
  • One object of the present invention is to provide an improved process for producing L-threonine by fermentation which can give a much higher accumulated amount and yield.
  • Another object of the invention is to provide an improved process using novel mutanized microorganisms for producing L-threonine.
  • a process for producing L-threonine by fermentation which comprises the steps of:
  • the microorganism used in the present invention belongs to the genus Providencia.
  • the genus is decided according to Bergy's Manual of Systematic Bacteriology Volume 1 (1984) pages 495 to 496.
  • the microorganism used in the invention requires at least L-leucine for the growth thereof and is capable of producing L-threonine.
  • lysine analog means (i) a substance which can inhibit the growth of the microorganism belonging to the genus Providencia, such an inhibition being reversed by supplement of lysine, or (ii) a substance which can repress or inhibit enzyme in the biosynthetic pathway of L-lysine.
  • lysine analog examples are S-aminoethyl-L-cystein, lysine hydroxamate, 4-hydroxylysine, and so on.
  • S-aminoethyl-L-cystein is most preferably used.
  • microorganisms which have further characters selected from the character requiring L-isoleucine for the growth thereof, the character having resistance to threonine analog such as ⁇ -amino- ⁇ -hydroxyvaleric acid, and the character having resistance to methionine analog such as ethionine, adding to at least one character of the character lacking threonine aldolase and the character having a resistance to lysine analog.
  • microorganisms which have some or all of the characters above mentioned. These characters can be given to the microorganisms by conventional methods.
  • auxotrophy namely requiring a nutrient for the growth thereof, means a wide concept and includes the leaky type, namely the incomplete defect type, and further includes the case when auxotrophy is supplied with a biosynthetic precursor of the required nutrient.
  • microorganisms useful for the invention are as follows:
  • This NS-140 strain has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid and ethionine; and requires L-isoleucine and L-leucine for the growth thereof, and was deposited with Fermentation Research Institute in Japan on Feb. 12, 1985.
  • This NS133I-69 strain has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid and ethionine; requires L-isoleucine and L-leucine for the growth thereof; and lacks threonine aldolase, and was deposited with Fermentation Research Institute in Japan on Feb. 12, 1985.
  • This TP4-105-43 strain has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid, L-ethionine, and S-aminoethyl-L-cysteine; and requires L-isoleucine and L-leucine for the growth thereof, and was deposited with Fermentation Research Institute in Japan on July 15, 1985.
  • the FERM BP numbers are the access number of the Fermentation Research Institute Agency of Industrial Science and Technology, at No. 1-3, Yatabe-cho, Higashi 1-chome, Tsukuba-gun, Ibaragi-ken, 305 JAPAN, from which the microorganisms with FERM BP numbers are available to any party who requests them.
  • threonine producing microorganisms can be derived as a mutant, for example, from the following parent strains of Proteus rettgeri which is the previous name of Providencia rettgeri;
  • This NS-133 strain has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid and ethionine; requires L-isoleucine for the growth thereof; and lacks threonine aldolase, and is a parent strain of NS133I-69.
  • NS133I-69 strain is a parent strain of TP3-105 which is a parent strain of TP4-105-43.
  • methods for inducing the mutants are conventional methods such as irradiation with ultraviolet light, or treatment with N-methyl-N'-nitro-N-nitrosoguanidine or ethylmethane sulfonate, etc.
  • the mutagenized cells are spread on the minimal agar plates containing a small amount of casamino acid (Trade Mark) or yeast extract and cultivated at 30° C. for 3 or 5 days. Smaller colonies formed on the agar plates are isolated, and the colony which requires L-leucine for the growth thereof is selected.
  • the microorganisms having a resistance to lysine analog when used, we define the microorganisms for the present invention as a strain which can grow and form colonies on a minimal medium supplemented with 2.5 g/l of lysine analog and of which the growth degree after the cultivation for 24 hours is at least 50%, based on the case in the absence of lysine analog.
  • growth degree is shown by the relative optical density of the culture broth at 660 nm when the optical density of culture broth in non-supplement of lysine analog is defined as 100%.
  • the processes for producing L-threonine using the microorganisms are conventional, and the microorganisms are cultivated in a conventional medium containing carbon sources, nitrogen sources, inorganic salts and other necessary organic minor nutrients.
  • carbohydrates such as glucose, fructose, starch, cellulose hydrolysate, or molasses
  • organic acids such as fumaric acid, citric acid, or succinic acid
  • alcohols such as glycerol.
  • organic ammonium compounds such as ammonium acetate, or urea
  • inorganic ammonium compounds such as ammonium sulfate, ammonium chloride, ammonium phosphate, or ammonimum nitratc
  • ammonia gas or aqueous ammonia.
  • potassium phosphate potassium phosphate
  • magnesium sulfate ferrous sulfate 7-hydrate or 4-to 6-hydrate of manganese sulfate.
  • the preferable culture medium may contain 2 to 15% of carbon source, 0.5 to 4.0% of nitrogen source, and 0.001 to 0.4% of required organic material, 0 to 4% of natural organic nutrient and a minor amount of inorganic nutrient.
  • Cultivation is carried out under aerobic conditions such as being shaken or stirred with aeration at a temperature from 24° to 37° C. for 48 to 120 hours. During cultivation the pH of the medium is adjusted to 5 to 9.
  • L-threonine in the culture broth thus obtained can be separated by a known method, for example, by means of ion-exchange resins.
  • the microorganisms are removed from the culture broth with centrifuging, and the resulting culture broth solution is adjusted to pH 2 by hydrochloric acid, and then the broth solution is passed through a strongly acidic cation exchange resin. Thereafter, the adsorbant is eluted by dilute aqueous ammonia. Ammonia is evaporated from the resulting eluent, and then the resulting solution is condensed. Alcohol is added to the resultant and left standing under cooling to give crystals of L-threonine.
  • Providencia rettgeri TY-1and NS-133 were irradiated with ultraviolet light by a conventional method, respectively.
  • the mutagenized cells were spread on the agar plates shown in Table 1.
  • NS-140 strain which has a resistance to a ⁇ -amino- ⁇ -hydroxyvaleric acid and ethionine and requires L-isoleucine and L-leucine
  • NS133I-69 strain which has a resistance to ⁇ -amino - ⁇ -hydroxyvaleric acid and ethionine, requires L-isoleucine and L-leucine for the growth thereof, and lacks threonine aldolase, was obtained from the parent NS-133 strain.
  • TP3-105 strain which has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid and L-ethionine, and requires L-isoleucine and L-leucine, was obtained.
  • TP3-105 strain was treated with N-methyl-N'-nitro-N-nitrosoguanidine by a conventional method (300 ⁇ g/ml, 30° C., 10 minutes).
  • the mutagenized cells were spread on the agar plate shown in Table 2.
  • TP4-105-43 strain which has a resistance to ⁇ -amino- ⁇ -hydroxyvaleric acid, L-ethionine and S-aminoethyl-L-cysteine and requires L-isoleucine and L-leucine for the growth thereof.
  • Each strain showing in Table 4 was cultivated on nutrient agar slant for 24 hours. The resulting strains were placed on the minimal agar plate shown in Table 3 containing no L-leucine and 0.01% of L-leucine and cultivated at 30° C. for 4 days.
  • the growth degree was measured.
  • the mutant requiring L-leucine was determined by one which is incapable or difficult to grow in the absence of L-leucine and capable to grow in the presence of L-leucine.
  • Providencia rettgeri NS-140, NS133I-69, and TP4-105-43 apparently require L-leucine for the growth thereof, while Providencia rettgeri TY-1 and NS-133 which are parent strains, do not.
  • Each microorganism shown in Table 6 was cultivated in bouillon liquid at 30° C. for 16 hours with shaking, was harvested, and washed well with physiological saline.
  • the resulting cell suspension of each microorganism was inoculated into 5 ml of the minimal medium shown in Table 5 containing 0 g/l, 2.5 g/l, 5 g/l, 7.5 g/l, 10 g/l, respectively, and cultivated at 30° C. for 14 hours.
  • the growth degree was measured.
  • Each microorganism shown in Table 8 was cultivated in bouillon liquid at 30° C. for 16 hours with shaking to give a seed culture broth. Then, 4 ml of seed culture broth was inoculated into 40 ml of the fermentation medium shown in Table 7 in 1-liter shaking flask. Cultivation was carried out at 30° C. for 90 hours with shaking conditions 150 rpm, 3 cm stroke).
  • the amounts of L-threonine accumulated and the yields were efficiently improved, compared with the parent strains.
  • Providencia rettgeri NS-140 was cultivated in bouillon liquid medium at 30° C. for 16 hours with shaking to give a seed culture broth.
  • 100 ml of the seed culture was transferred into a 2-liter jar fermentor, which contained 900 ml of the same fermentation medium as used in Example 1 except that 0.5% of (NH 4 ) 2 SO 4 and 4.0% of glucose was used.
  • Cultivation was carried out at 30° C. with agitation (800 rpm) and with aeration (1 liter of air per min).
  • PH was controlled to 6.5 to 8.0 by 25% aqueous ammonia which was used as a nitrogen source.
  • glucose was fed intermittently and 150 g of glucose was consumed.
  • the culture broth was centrifuged and the microorganisms were removed off from the culture broth.
  • 500 ml of the filtrate was passed through a column packed with supernatant strong cation exchange resin DIAION (Trade Mark) SK ⁇ 1B [H type]. Then, the column was washed with water and thereafter the adsorbant in column was eluted by 2N aqueous ammonia. The eluent was decolorized and condensed under reduced pressure. Alcohol was added to the resultant and left standing under cooling to give crystals of L-threonine. The crystals were gathered, dried to give 11.5 g of L-threonine having 96% of the purity.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Microorganisms belonging to the genus Providencia the species rettgeri at least leucine for the growth thereof, produce L-threonine by fermentation in higher yield and with increased amount of L-threonine accumulated.

Description

This application is a continuation of application Ser. No. 861,076, filed May 8, 1986, now abandoned.
BACKGROUND OF THE INVENTION
(a) FIELD OF THE INVENTION
This invention relates to a process for producing L-threonine by fermentation.
(b) PRIOR ART
It hitherto has been known that the microorganism belonging to the genus Proteus or Providencia of which the mutant requires L-isoleucine, can be used as microorganisms capable of producing L-threonine by fermentation (Japanese Examined Patent Publication No. 4440/1968).
However, there is room for further improvement in the capability of the strains as to the amount of L-threonine accumulated and as to the yield of L-threonine from the starting material such as glucose or fructose.
SUMMARY OF THE INVENTION
One object of the present invention is to provide an improved process for producing L-threonine by fermentation which can give a much higher accumulated amount and yield.
Another object of the invention is to provide an improved process using novel mutanized microorganisms for producing L-threonine.
These and other objects of the invention will become more apparent in the detailed description and examples hereinafter.
These objects are attained by
A process for producing L-threonine by fermentation which comprises the steps of:
(a) culturing an L-threonine producing microorganism belonging to the genus Providencia until L-threonine is accumulated in a culture broth, said microorganism requiring at least leucine for the growth thereof and
(b) recovering the accumulated L-threonine from the culture broth.
PREFERRED EMBODIMENTS
The microorganism used in the present invention belongs to the genus Providencia. The genus is decided according to Bergy's Manual of Systematic Bacteriology Volume 1 (1984) pages 495 to 496. Moreover, the microorganism used in the invention requires at least L-leucine for the growth thereof and is capable of producing L-threonine. In the invention there may preferably be employed microorganisms which further have the character of lacking threonine aldolase and/or the character of having resistance to lysine analog.
In the invention "lysine analog" means (i) a substance which can inhibit the growth of the microorganism belonging to the genus Providencia, such an inhibition being reversed by supplement of lysine, or (ii) a substance which can repress or inhibit enzyme in the biosynthetic pathway of L-lysine.
Preferable examples of the lysine analog are S-aminoethyl-L-cystein, lysine hydroxamate, 4-hydroxylysine, and so on. As for the lysine analog S-aminoethyl-L-cystein is most preferably used.
These characters effectively operate the capability of producing L-threonine.
Moreover, there may be more preferably employed microorganisms which have further characters selected from the character requiring L-isoleucine for the growth thereof, the character having resistance to threonine analog such as α-amino-β-hydroxyvaleric acid, and the character having resistance to methionine analog such as ethionine, adding to at least one character of the character lacking threonine aldolase and the character having a resistance to lysine analog.
These characters also effectively operate the capability of producing L-threonine. Therefore, there may be more preferably employed microorganisms which have some or all of the characters above mentioned. These characters can be given to the microorganisms by conventional methods.
In the present invention, auxotrophy, namely requiring a nutrient for the growth thereof, means a wide concept and includes the leaky type, namely the incomplete defect type, and further includes the case when auxotrophy is supplied with a biosynthetic precursor of the required nutrient.
Representative microorganisms useful for the invention are as follows:
(a) Providencia rettgeri NS-140 (FERM BP-1057)
This NS-140 strain has a resistance to α-amino-β-hydroxyvaleric acid and ethionine; and requires L-isoleucine and L-leucine for the growth thereof, and was deposited with Fermentation Research Institute in Japan on Feb. 12, 1985.
(b) Providencia rettgeri NS133I-69 (FERM BP-1058)
This NS133I-69 strain has a resistance to α-amino-β-hydroxyvaleric acid and ethionine; requires L-isoleucine and L-leucine for the growth thereof; and lacks threonine aldolase, and was deposited with Fermentation Research Institute in Japan on Feb. 12, 1985.
(c) Providencia rettgeri TP4-105-43 (FERM BP-1050)
This TP4-105-43 strain has a resistance to α-amino-β-hydroxyvaleric acid, L-ethionine, and S-aminoethyl-L-cysteine; and requires L-isoleucine and L-leucine for the growth thereof, and was deposited with Fermentation Research Institute in Japan on July 15, 1985.
The FERM BP numbers are the access number of the Fermentation Research Institute Agency of Industrial Science and Technology, at No. 1-3, Yatabe-cho, Higashi 1-chome, Tsukuba-gun, Ibaragi-ken, 305 JAPAN, from which the microorganisms with FERM BP numbers are available to any party who requests them.
These threonine producing microorganisms can be derived as a mutant, for example, from the following parent strains of Proteus rettgeri which is the previous name of Providencia rettgeri;
(i) Providencia rettgeri TY-1 (FERM P-8079) This TY-1 strain has a resistance to α-amino-β-hydroxyvaleric acid and ethionine; and requires L-isoleucine for the growth thereof and is a parent strain of NS-140.
(ii) Providencia rettgeri NS-133 (FERM P-8079)
This NS-133 strain has a resistance to α-amino-β-hydroxyvaleric acid and ethionine; requires L-isoleucine for the growth thereof; and lacks threonine aldolase, and is a parent strain of NS133I-69. Moreover, NS133I-69 strain is a parent strain of TP3-105 which is a parent strain of TP4-105-43.
In the invention, methods for inducing the mutants are conventional methods such as irradiation with ultraviolet light, or treatment with N-methyl-N'-nitro-N-nitrosoguanidine or ethylmethane sulfonate, etc. After the irradiation or treatment, the mutagenized cells are spread on the minimal agar plates containing a small amount of casamino acid (Trade Mark) or yeast extract and cultivated at 30° C. for 3 or 5 days. Smaller colonies formed on the agar plates are isolated, and the colony which requires L-leucine for the growth thereof is selected.
When the microorganisms having a resistance to lysine analog is used, we define the microorganisms for the present invention as a strain which can grow and form colonies on a minimal medium supplemented with 2.5 g/l of lysine analog and of which the growth degree after the cultivation for 24 hours is at least 50%, based on the case in the absence of lysine analog. In the invention, growth degree is shown by the relative optical density of the culture broth at 660 nm when the optical density of culture broth in non-supplement of lysine analog is defined as 100%.
The processes for producing L-threonine using the microorganisms are conventional, and the microorganisms are cultivated in a conventional medium containing carbon sources, nitrogen sources, inorganic salts and other necessary organic minor nutrients.
There can be used as a carbon source, carbohydrates such as glucose, fructose, starch, cellulose hydrolysate, or molasses; organic acids such as fumaric acid, citric acid, or succinic acid; or alcohols such as glycerol.
There can be used as a nitrogen source, organic ammonium compounds such as ammonium acetate, or urea; inorganic ammonium compounds such as ammonium sulfate, ammonium chloride, ammonium phosphate, or ammonimum nitratc; ammonia gas; or aqueous ammonia.
There can be preferably used as organic nutrients corn steep liquor, polypeptone, or yeast extract.
There can be used as an inorganic salt, potassium phosphate, magnesium sulfate, ferrous sulfate 7-hydrate or 4-to 6-hydrate of manganese sulfate.
The preferable culture medium may contain 2 to 15% of carbon source, 0.5 to 4.0% of nitrogen source, and 0.001 to 0.4% of required organic material, 0 to 4% of natural organic nutrient and a minor amount of inorganic nutrient.
Cultivation is carried out under aerobic conditions such as being shaken or stirred with aeration at a temperature from 24° to 37° C. for 48 to 120 hours. During cultivation the pH of the medium is adjusted to 5 to 9.
After cultivation, L-threonine in the culture broth thus obtained can be separated by a known method, for example, by means of ion-exchange resins. In order to recover the accumulated L-threonine from the culture broth, the microorganisms are removed from the culture broth with centrifuging, and the resulting culture broth solution is adjusted to pH 2 by hydrochloric acid, and then the broth solution is passed through a strongly acidic cation exchange resin. Thereafter, the adsorbant is eluted by dilute aqueous ammonia. Ammonia is evaporated from the resulting eluent, and then the resulting solution is condensed. Alcohol is added to the resultant and left standing under cooling to give crystals of L-threonine.
The invention will be more clearly understood with reference to the following Experiments and Examples. However, these Experiments and Examples are intended to illustrate the invention and are not to be construed as limiting the scope of the invention.
EXPERIMENT 1 Isolation of the mutant strain requiring L-leucine for the growth thereof
Providencia rettgeri TY-1and NS-133 were irradiated with ultraviolet light by a conventional method, respectively. The mutagenized cells were spread on the agar plates shown in Table 1.
              TABLE 1                                                     
______________________________________                                    
COMPONENTS OF MEDIUM FOR AGAR PLATE                                       
______________________________________                                    
       Glucose        0.5%                                                
       (NH.sub.4).sub.2 SO.sub.4                                          
                      0.1%                                                
       KH.sub.2 PO.sub.4                                                  
                      0.3%                                                
       K.sub.2 HPO.sub.4                                                  
                      0.7%                                                
       MgSO.sub.4.7H.sub.2 O                                              
                      0.01%                                               
       L-isoleucine   0.005%                                              
       Polypeptone    0.01%                                               
       Agar           2%                                                  
______________________________________                                    
Then, the agar plates were incubated for 4 to 6 days at 30° C. In the colonies formed on the plate, smaller colonies were picked up from the colonies formed on the plate. NS-140 strain, which has a resistance to a α-amino-β-hydroxyvaleric acid and ethionine and requires L-isoleucine and L-leucine, was obtained from the parent TY-1 strain. NS133I-69 strain, which has a resistance to α-amino -β-hydroxyvaleric acid and ethionine, requires L-isoleucine and L-leucine for the growth thereof, and lacks threonine aldolase, was obtained from the parent NS-133 strain.
EXPERIMENT 2 Isolation of the mutant strain requiring L-leucine for the growth thereof and having a resistance to S-aminoethyl-L-cysteine
Providencia rettgeri NS133I-69 strain was irradiated with ultraviolet light by a similar manner to Experiment 1. TP3-105 strain, which has a resistance to α-amino-β-hydroxyvaleric acid and L-ethionine, and requires L-isoleucine and L-leucine, was obtained. TP3-105 strain was treated with N-methyl-N'-nitro-N-nitrosoguanidine by a conventional method (300 μg/ml, 30° C., 10 minutes).
The mutagenized cells were spread on the agar plate shown in Table 2.
              TABLE 2                                                     
______________________________________                                    
COMPONENTS OF MEDIUM FOR AGAR PLATE                                       
______________________________________                                    
Glucose                 0.5%                                              
(NH.sub.4).sub.2 SO.sub.4                                                 
                        0.1%                                              
KH.sub.2 PO.sub.4       0.3%                                              
K.sub.2 HPO.sub.4       0.7%                                              
MgSO.sub.4.7H.sub.2 O   0.01%                                             
L-leucine               0.005%                                            
S-aminoethyl-L-cysteine 0.8%                                              
L-threonine             1.0%                                              
L-isoleucine            1.0%                                              
L-methionine            1.0%                                              
Agar                    2%                                                
______________________________________                                    
Then the agar plates were incubated for 5 to 7 days at 30° C. In the colonies formed on the plate, larger colony was picked up from colonies formed on the plate and obtained TP4-105-43 strain which has a resistance to α-amino-β-hydroxyvaleric acid, L-ethionine and S-aminoethyl-L-cysteine and requires L-isoleucine and L-leucine for the growth thereof.
EXPERIMENT 3 Test of L-leucine auxotrophy
Each strain showing in Table 4 was cultivated on nutrient agar slant for 24 hours. The resulting strains were placed on the minimal agar plate shown in Table 3 containing no L-leucine and 0.01% of L-leucine and cultivated at 30° C. for 4 days.
              TABLE 3                                                     
______________________________________                                    
COMPONENTS OF MINIMAL                                                     
MEDIUM FOR AGAR PLATE                                                     
______________________________________                                    
       Glucose        0.5%                                                
       (NH.sub.4)SO.sub.4                                                 
                      0.1%                                                
       KH.sub.2 PO.sub.4                                                  
                      0.3%                                                
       K.sub.2 HPO.sub.4                                                  
                      0.7%                                                
       MgSO.sub.4.7H.sub.2 O                                              
                      0.01%                                               
       L-isoleucine   0.005%                                              
       Agar           2.0%                                                
______________________________________                                    
The growth degree was measured. The mutant requiring L-leucine was determined by one which is incapable or difficult to grow in the absence of L-leucine and capable to grow in the presence of L-leucine.
The results are shown in Table 4.
Providencia rettgeri NS-140, NS133I-69, and TP4-105-43 apparently require L-leucine for the growth thereof, while Providencia rettgeri TY-1 and NS-133 which are parent strains, do not.
              TABLE 4                                                     
______________________________________                                    
               Amount of L-leucine                                        
Microorganisms added (%)      Growth*.sup.)                               
______________________________________                                    
Providencia rettgeri                                                      
               0              +                                           
TY-1                                                                      
(Parent strain)                                                           
Providencia rettgeri                                                      
               0.01           +                                           
TY-1                                                                      
(Parent strain)                                                           
Providencia rettgeri                                                      
               0              -                                           
NS-140                                                                    
Providencia rettgeri                                                      
               0.01           +                                           
NS-140                                                                    
Providencia rettgeri                                                      
               0              +                                           
NS-133                                                                    
(Parent strain)                                                           
Providencia rettgeri                                                      
               0.01           +                                           
NS-133                                                                    
(Parent strain)                                                           
Providencia rettgeri                                                      
               0              -                                           
NS133I-69                                                                 
Providencia rettgeri                                                      
               0.01           +                                           
NS133I-69                                                                 
Providencia rettgeri                                                      
               0              -                                           
TP4-105-43                                                                
Providencia rettgeri                                                      
               0.01           +                                           
TP4-105-43                                                                
______________________________________                                    
 *.sup.) +: Grow                                                          
 -: Not grow                                                              
EXPERIMENT 4 Test of resistance to S-aminoethyl-L-cystein
Each microorganism shown in Table 6 was cultivated in bouillon liquid at 30° C. for 16 hours with shaking, was harvested, and washed well with physiological saline. The resulting cell suspension of each microorganism was inoculated into 5 ml of the minimal medium shown in Table 5 containing 0 g/l, 2.5 g/l, 5 g/l, 7.5 g/l, 10 g/l, respectively, and cultivated at 30° C. for 14 hours.
              TABLE 5                                                     
______________________________________                                    
Minimal medium                                                            
______________________________________                                    
       Glucose        0.5%                                                
       (NH.sub.4)SO.sub.4                                                 
                      0.1%                                                
       KH.sub.2 PO.sub.4                                                  
                      0.3%                                                
       K.sub.2 HPO.sub.4                                                  
                      0.7%                                                
       MgSO.sub.4.7H.sub.2 O                                              
                      0.01%                                               
       L-isoleucine   0.005%                                              
       L-leucine      0.005%                                              
       Agar           2.0%                                                
______________________________________                                    
The growth degree was measured.
The results are shown in Table 6. Providencia rettgeri TP4-1105-43 is not inhibited the growth in the presence of the high concentration of S-aminoethyl-L-cysteine and has a strong resistance to S-aminoethyl-L-cysteine.
              TABLE 6                                                     
______________________________________                                    
         Relative growth degree*.sup.) (%)                                
         Amount of S-aminoethyl-L-cysteine                                
         added (g/l)                                                      
Microorganisms                                                            
           0       2.5     5     7.5   10                                 
______________________________________                                    
Providencia                                                               
           100     4       4     4     4                                  
rettgeri   (61.0)  (3.6)   (4.4) (4.3) (4.6)**.sup.)                      
TP3-105                                                                   
Providencia                                                               
           100     92      83    55    55                                 
rettgeri   (68.2)  (63.0)  (56.9)                                         
                                 (37.6)                                   
                                       (37.5)**.sup.)                     
TP4-105-43                                                                
______________________________________                                    
 *.sup.) Relative growth degree is shown by the relative optical density o
 the culture broth at 660 nm when the optical density of the cultrue broth
 in the absence of Saminoethyl-L-cysteine is 100%.                        
 **.sup.) Optical density of the culture broth at 660 nm.                 
EXAMPLE 1 Production of L-threonine
Each microorganism shown in Table 8 was cultivated in bouillon liquid at 30° C. for 16 hours with shaking to give a seed culture broth. Then, 4 ml of seed culture broth was inoculated into 40 ml of the fermentation medium shown in Table 7 in 1-liter shaking flask. Cultivation was carried out at 30° C. for 90 hours with shaking conditions 150 rpm, 3 cm stroke).
              TABLE 7                                                     
______________________________________                                    
FERMENTATION MEDIUM*.sup.)                                                
______________________________________                                    
Glucose                8%                                                 
(autoclaved separately)                                                   
(NH.sub.4).sub.2 SO.sub.4                                                 
                       2%                                                 
KH.sub.2 PO.sub.4      0.1%                                               
MgSO.sub.4.7H.sub.2 O  0.04%                                              
Fe.sup.++              2 ppm                                              
Mn.sup.++              2 ppm                                              
L-Isoleucine           0.0025%                                            
L-Leucine              0.08%**.sup.)                                      
CaCO.sub.3             4%                                                 
(autoclaved separately)                                                   
pH                     7.0                                                
(neutralized with KOH)                                                    
______________________________________                                    
 *.sup.) Main culture medium was previously sterilized at 115° C.  
 for 10 minutes.                                                          
 **.sup.) L-leucine was added in using NS140 and NS133I-69.               
After cultivation, the medium was filtrated and removed off microorganisms and calcium carbonate, the amount of L-threonine accumulated in the resulting filtrate was quantitatively analyzed by automatic amino acid analyser (Produced by Japan Electric Co., JLC 200A). The results are shown in Table 8.
              TABLE 8                                                     
______________________________________                                    
                  Amount of L- Yield of                                   
                  threonine    L-threonine                                
Microorganisms    accumulated (g/l)                                       
                               (%)*.sup.)                                 
______________________________________                                    
Providencia rettgeri TY-1                                                 
                  9.6          12.0                                       
(Parent strain)                                                           
Providencia rettgeri NS-140                                               
                  13.2         16.5                                       
Providencia rettgeri NS-133                                               
                  11.5         14.4                                       
(Parent strain)                                                           
Providencia rettgeri NS133I-69                                            
                  15.2         19.0                                       
Providencia rettgeri TP3-105                                              
                  10.4         19.0                                       
Providencia rettgeri TP4-105-43                                           
                  20.7         26.7                                       
______________________________________                                    
 *.sup.) Yield was calculated by weight of produced Lthreonine based on   
 consumed glucose.                                                        
In examples of the present invention, the amounts of L-threonine accumulated and the yields were efficiently improved, compared with the parent strains.
EXAMPLE 2 Production of L-threonine
Providencia rettgeri NS-140 was cultivated in bouillon liquid medium at 30° C. for 16 hours with shaking to give a seed culture broth. 100 ml of the seed culture was transferred into a 2-liter jar fermentor, which contained 900 ml of the same fermentation medium as used in Example 1 except that 0.5% of (NH4)2 SO4 and 4.0% of glucose was used. Cultivation was carried out at 30° C. with agitation (800 rpm) and with aeration (1 liter of air per min). PH was controlled to 6.5 to 8.0 by 25% aqueous ammonia which was used as a nitrogen source. During cultivation, glucose was fed intermittently and 150 g of glucose was consumed.
After cultivation of 76 hours, 26.0 g/l for L-threonine, which was 17.3 wt % was based on glucose, was produced.
The culture broth was centrifuged and the microorganisms were removed off from the culture broth. 500 ml of the filtrate was passed through a column packed with supernatant strong cation exchange resin DIAION (Trade Mark) SK·1B [H type]. Then, the column was washed with water and thereafter the adsorbant in column was eluted by 2N aqueous ammonia. The eluent was decolorized and condensed under reduced pressure. Alcohol was added to the resultant and left standing under cooling to give crystals of L-threonine. The crystals were gathered, dried to give 11.5 g of L-threonine having 96% of the purity.

Claims (2)

What we claim is:
1. A process for producing L-threonine by fermentation which comprises the steps of:
(a) culturing an L-threonine producing microorganism selected from the group consisting of Providencia rettgeri FERM BP-1050 (TP4-105-43), Providencia rettgeri FERM BP-1057 (NS-140) and Providencia rettgeri FERM BP-1058 NS133I-69) until L-threonine is accumulated in a culture broth, and
(b) recovering the accumulated L-threonine from the culture broth.
2. A process for producing L-threonine by fermentation which comprises the steps of:
(a) culturing an L-threonine producing microorganism selected from the group consisting of mutants of Providencia rettgeri FERM BP-871 (TY-1) and Providencia rettgeri FERM BP-3361 (NS133) until L-threonine is accumulated in a culture broth, said microorganism requiring at least leucine for the growth thereof; and
(b) recovering the accumulated L-threonine from the culture broth.
US07/357,690 1985-05-13 1989-05-25 Process for producing l-threonine by fermentation Expired - Fee Related US5098835A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP9958985A JPS61260891A (en) 1985-05-13 1985-05-13 Production of l-threonine by fermentation method
JP60-99589 1985-05-13
JP4258086A JPH0673460B2 (en) 1986-02-27 1986-02-27 Method for producing L-threonine by fermentation method
JP61-42580 1986-02-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US06861076 Continuation 1986-05-08

Publications (1)

Publication Number Publication Date
US5098835A true US5098835A (en) 1992-03-24

Family

ID=26382291

Family Applications (1)

Application Number Title Priority Date Filing Date
US07/357,690 Expired - Fee Related US5098835A (en) 1985-05-13 1989-05-25 Process for producing l-threonine by fermentation

Country Status (3)

Country Link
US (1) US5098835A (en)
EP (1) EP0205849B1 (en)
DE (1) DE3682709D1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939307A (en) * 1996-07-30 1999-08-17 The Archer-Daniels-Midland Company Strains of Escherichia coli, methods of preparing the same and use thereof in fermentation processes for l-threonine production
US20020106800A1 (en) * 2000-09-28 2002-08-08 Liaw Hungming J. Escherichia coli strains which over-produce L-thereonine and processes for the production of L-threonine by fermentation
US20060205044A1 (en) * 2005-03-11 2006-09-14 D Elia John N Escherichia coli strains that over-produce L-threonine and processes for their production
US20070015261A1 (en) * 2005-06-20 2007-01-18 D Elia John N Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243496A4 (en) * 1985-08-26 1988-01-28 Toray Industries Process for producing l-threonine by fermentation.
KR100815041B1 (en) 1999-08-02 2008-03-18 아처 다니엘 미드랜드 캄파니 Metabolic Engineering of Amino Acid Production
DE19959329A1 (en) 1999-12-09 2001-06-13 Degussa Process for the fermentative production of L-amino acids using coryneform bacteria
DE102005043979A1 (en) 2005-09-15 2007-03-22 Forschungszentrum Jülich GmbH Process for the production of amino acids in amino acid-producing microorganisms

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3375173A (en) * 1964-07-01 1968-03-26 Chugai Pharmaceutical Co Ltd Fermentation process for the production of l-threonine
US3893888A (en) * 1973-03-09 1975-07-08 Ajinomoto Kk Fermentative production of l-valine
JPS60180597A (en) * 1984-02-27 1985-09-14 Toray Ind Inc Production of l-threonine by fermentation
EP0213536A2 (en) * 1985-08-23 1987-03-11 Toray Industries, Inc. Process for producing L-threonine by fermentation
JPH08216690A (en) * 1995-02-17 1996-08-27 Honda Motor Co Ltd Glass sunroof panel
JPH08224684A (en) * 1994-11-28 1996-09-03 Sollac Device to guide and feed sheet base stock

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3375173A (en) * 1964-07-01 1968-03-26 Chugai Pharmaceutical Co Ltd Fermentation process for the production of l-threonine
US3893888A (en) * 1973-03-09 1975-07-08 Ajinomoto Kk Fermentative production of l-valine
JPS60180597A (en) * 1984-02-27 1985-09-14 Toray Ind Inc Production of l-threonine by fermentation
EP0213536A2 (en) * 1985-08-23 1987-03-11 Toray Industries, Inc. Process for producing L-threonine by fermentation
JPH08224684A (en) * 1994-11-28 1996-09-03 Sollac Device to guide and feed sheet base stock
JPH08216690A (en) * 1995-02-17 1996-08-27 Honda Motor Co Ltd Glass sunroof panel

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
Agric. Biol. Chem., vol. 38, No. 5, 1974, pp. 993 1000, Kase et al. *
Agric. Biol. Chem., vol. 38, No. 5, 1974, pp. 993-1000, Kase et al.
Chemical Abstracts, vol. 81, No. 4, Aug. 19, 1974, p. 310, No. 36502b. *
Lynn et al., In, "Amino Acids", Addison Wesley, 1983, pp. 173-179.
Lynn et al., In, Amino Acids , Addison Wesley, 1983, pp. 173 179. *
Stanbury et al., Principles of Fermentation Technology , 1989, pp. 40 47. *
Stanbury et al., Principles of Fermentation Technology, 1989, pp. 40-47.
Tosaka et al. (I), Agric. Biol. Chem. vol. 42, pp. 745 752, 1978. *
Tosaka et al. (I), Agric. Biol. Chem. vol. 42, pp. 745-752, 1978.
Tosaka et al. (II), Agric. Biol. Chem. vol. 42, pp. 1501 1506, 1978. *
Tosaka et al. (II), Agric. Biol. Chem. vol. 42, pp. 1501-1506, 1978.
Yoshinaga et al., In, "Amino Acids", pp. 405-429.
Yoshinaga et al., In, Amino Acids , pp. 405 429. *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939307A (en) * 1996-07-30 1999-08-17 The Archer-Daniels-Midland Company Strains of Escherichia coli, methods of preparing the same and use thereof in fermentation processes for l-threonine production
US20020106800A1 (en) * 2000-09-28 2002-08-08 Liaw Hungming J. Escherichia coli strains which over-produce L-thereonine and processes for the production of L-threonine by fermentation
US7220571B2 (en) 2000-09-28 2007-05-22 Archer-Daniels-Midland Company Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation
US20080166788A1 (en) * 2000-09-28 2008-07-10 Archer-Daniels-Midland Company Escherichia Coli Strains which Over-Produce L-Threonine and Processes for the Production of L-Threonine by Fermentation
US7687253B2 (en) 2000-09-28 2010-03-30 Archer-Daniels-Midland Company Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation
US7767431B2 (en) 2000-09-28 2010-08-03 Archer-Daniels-Midland Company Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation
US8101386B2 (en) 2000-09-28 2012-01-24 Archer Daniels Midland Company Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation
US20060205044A1 (en) * 2005-03-11 2006-09-14 D Elia John N Escherichia coli strains that over-produce L-threonine and processes for their production
US7723097B2 (en) 2005-03-11 2010-05-25 Archer-Daniels-Midland Company Escherichia coli strains that over-produce L-threonine and processes for their production
US20100159537A1 (en) * 2005-03-11 2010-06-24 D Elia John N Escherichia coli strains that over-produce l-threonine and processes for their production
US20070015261A1 (en) * 2005-06-20 2007-01-18 D Elia John N Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals
US8187842B2 (en) 2005-06-20 2012-05-29 Archer Daniels Midland Company Altered glyoxylate shunt for improved production of aspartate-derived amino acids and chemicals

Also Published As

Publication number Publication date
EP0205849A3 (en) 1988-03-23
EP0205849B1 (en) 1991-12-04
DE3682709D1 (en) 1992-01-16
EP0205849A2 (en) 1986-12-30

Similar Documents

Publication Publication Date Title
CA2082347C (en) Process for producing l-isoleucine
US4529697A (en) Process for producing L-glutamic acid by fermentation
HU215545B (en) Process for producing l-threonine
US5264353A (en) Process for producing L-threonine by fermentation
US5098835A (en) Process for producing l-threonine by fermentation
US3970519A (en) Process for producing L-leucine
US5217883A (en) Process for producing amino acid
JPS6257315B2 (en)
US5460958A (en) Process for producing L-isoleucine by S-2-aminoethyl-L-cysteine or D-Serine resistant strains of E coli
US3871960A (en) Method of producing l-lysine by fermentation
US5087566A (en) Process for producing l-threonine
EP0213536B1 (en) Process for producing l-threonine by fermentation
US5342766A (en) Process for producing L-threonine by fermentation with P. rettgeri.
US4389483A (en) Method for producing L-glutamic acid by fermentation
US4601982A (en) Method for producing L-tryptophan by fermentation with a brevibacterium flavum mutant
US4742007A (en) Process for the preparation of L-tryptophan
US3880741A (en) Method of producing L-serine
US5302521A (en) Process for producing L-lysine by iodothyronine resistant strains of Mucorynebacterium glutamicum
CA2037832A1 (en) Process for producing l-threonine
US4560652A (en) Process for producing L-tryptophan by fermentation
US5034319A (en) Process for producing L-arginine
CA1192156A (en) Fermentative preparation of l-leucine
US4421853A (en) Fermentative preparation of L-leucine
KR0146493B1 (en) Process for producing l-alanine by fermentation
US4123329A (en) Process for producing L-lysine by fermentation

Legal Events

Date Code Title Description
CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 20000324

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362